Citations

Mayo Clinic

Clear

88160 citation(s) found for "NA".

Sports and Exercise Cardiology: A New Frontier in Cardiovascular Disease Management
Cornwell, William K. , Dineen, Elizabeth H. , Petek, Bradley J. , Shafer, Keri M. , Davenport, Eddie D , Chung, Eugene H. , Kim, Jonathan H. , Levine, Benjamin D. , Davenport, Eddie , Levine, Benjamin D

Circulation: Population Health and Outcomes | July 9, 2026 | Volume: 19 | Issue: 8 | Pages: No page available

10.1161/circoutcomes.126.013583 | PMID 42422937 Get It

Exercise and physical activity are recognized as essential tools to optimize fitness and longevity, improve overall health, and reduce the risk of cardiovascular disease and other major comorbidities. However, there are inherent risks associated with participation in sports and exercise, regardless of the level of competition or skill required. As such, there is a need for cardiologists to understand the unique aspects of competitive and recreational athletics, as well as sport and exercise science, as it relates to overall heart health and cardiovascular risk. In this article, we provide an overview of the essential aspects of sports and exercise cardiology. We describe the roles and responsibilities of a sports and exercise cardiologist as a member of a comprehensive team of experts who provide care of athletes at all levels of sport, emphasize the importance of risk stratification and prevention of sudden cardiac arrest, the role of exercise for maintaining and optimizing overall health in the general population, describe the growing field of sports electrophysiology and also discuss unique aspects of sports cardiology applied to environmental health and care of the tactical athlete. Knowledge gaps and directions for future clinical and research investigation are reviewed.
Early Versus Late Recurrence in Olfactory Neuroblastoma: A Multi‐Institutional Analysis of Predictive Risk Factors
Harris, Alexandria , Tang, Anthony, Fung, Nicholas , Champagne, Pierre‐Olivier, Fernandez-Miranda, Juan, Gardner, Paul A. , Hwang, Peter H. , Kalyvas, Aristotelis, Patel, Zara M. , Patel, Zara M., Celda, María Peris, Pinheiro-Neto, Carlos D., Sanusi, Olabisi, Thorp, Brian D., Gompel, Jamie J. Van, Zenonos, Georgios, Zwagerman, Nathan T., Bell, Diana, Kuan, Edward C., Geltzeiler, Mathew, Hwang, Peter H , Patel, Zara , Snyderman, Carl H , Wang, Eric W , Choby, Garret , Tang, Anthony , Almeida, João Paulo , Champagne, Pierre‐Olivier , Kalyvas, Aristotelis , Pinheiro‐Neto, Carlos , Sanusi, Olabisi , Thorp, Brian D. , Gompel, Jamie J. Van , Zenonos, Georgios A. , Zwagerman, Nathan T. , Bell, Diana , Kuan, Edward C , Geltzeiler, Mathew , Choby, Garret

International Forum of Allergy & Rhinology | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/alr.70216 | PMID 42422976 Get It

ABSTRACT Background Olfactory neuroblastoma (ONB) exhibits variable recurrence patterns, with significant late recurrences occurring years after treatment. We investigated cutoff periods to define late recurrence and identified predictors that distinguish patients at risk of late recurrence from those considered cured. Methods From a multi‐institutional cohort of 219 ONB patients treated at nine centers, we analyzed 77 patients with documented recurrence. Using a 48‐month cutoff to define early (< 48 months) versus late (≥ 48 months) recurrence, we evaluated 35 clinical, anatomic, and treatment variables using Firth penalized logistic regression across three comparisons: (1) late versus early recurrence timing, (2) late recurrence versus no recurrence, and (3) early recurrence versus no recurrence. Results Thirty‐four of the 77 (44.2%) recurrences were classified as late. Among the 77 patients who recurred, smaller tumor volume (OR 0.243, p = 0.035) and lower novel Dulguerov staging (OR 0.802, p = 0.038) were associated with late, rather than early recurrence. When patients with late recurrence were compared to those who remained disease‐free, radiographic skull base bone involvement was the strongest independent predictor (OR 2.90, 95% CI 1.14–8.64, p = 0.025), and this effect strengthened after adjusting for tumor volume (OR 3.80, p = 0.029). Pathologic dural invasion (OR 3.29, p = 0.013), Kadish stage (OR 2.02, p = 0.026), and T‐stage (OR 1.32, p = 0.040) were also significant. Conclusions A 48‐month cutoff effectively stratifies ONB recurrence risk. Skull base bone involvement independently predicts recurrence when compared to nonrecurrent cases and uniquely persists as a risk factor for late recurrence. These findings establish skull base bone involvement as a novel biomarker for risk‐stratified surveillance protocols.
A novel classification of testicular sex cord‐stromal tumours from the Testicular Sex Cord‐Stromal Tumour ( TESST ) group: a collaboration of the Genitourinary Pathology Society (
Acosta, Andrés , Bremmer, Felix , Jc, Cheville, Colecchia, Maurizio , Comperat, Eva, Cornejo, Kristine, Baydar, Dilek E., Gill, A J, Gonzalez‐Peramato, Maria del Pilar, Gupta, Sounak , Hirsch, Michelle S. , Idrees, Muhammad T., Maclean, Fiona, Mohanty, Sambit K., Raspollini, Maria Rosaria , Sangoi, Ankur R , SHOLL, L B, Siegmund, S, Tickoo, Satish K., Tm, Ulbright, Yilmaz, Asli, Sangoi, Ankur R. , Acosta, Andrés M , Matoso, Andres , Menon, Santosh , Michalova, Kvetoslava , Reyes-Mugica, Miguel , Raspollini, Maria Rosaria , Sangoi, Ankur R , Tsuzuki, Toyonori , Berney, Daniel M , Sangoi, Ankur R , Compérat, Éva , Cornejo, Kristine M. , Baydar, Dilek Ertoy , González-Peramato, María Pilar, Idrees, Muhammad T. , Kao, Chia‐Sui , Maclean, Fiona M. , Mehra, Rohit, Mohanty, Sambit K. , Reyes‐Múgica, Miguel , Siegmund, Sophie C., Tickoo, Satish K. , Tsuzuki, Toyonori , Ulbright, Thomas M. , Williamson, Sean R. , Yilmaz, Aslı , Berney, Daniel M.

Histopathology | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/his.70207 | PMID 42421431 Get It

Aims Testicular sex cord‐stromal tumours (TSCSTs) are rare neoplasms that arise from (or show differentiation to) elements derived from the sex cords or intertubular stroma. The current classification (World Health Organization, 2022) is based almost entirely on morphology, with many tumour types such as granulosa cell tumours being defined based on their resemblance to ovarian counterparts. Recent studies have uncovered new clinicopathological, molecular and biological nuances within this group of tumours, underscoring differences with ovarian homologues. Methods and results Considering the new data, a group of genitourinary pathology experts (Testicular Sex Cord‐Stromal Tumour [TESST] group) has proposed a revised ‘TESST classification’ that incorporates the best available evidence. This classification is structured and hierarchical, composed of the following tiers: (1) group, (2) category, (3) entity and (4) histological pattern. ‘Group’ refers to the histological compartment a specific tumour belongs to (sex cords, stroma or both), whereas ‘category’ is defined by the phenotype of the tumour, taking non‐neoplastic elements of the ovary and testis as a reference. The third tier, ‘entity’, refers to neoplasms with shared clinicopathological and/or molecular features that justify classifying them as distinct types. Lastly, ‘histological patterns’ are recurrent morphological variations within entities that are not linked to distinct clinicopathological or molecular features. Conclusions We propose a classification that will provide a framework to improve current clinical management and guide future research in the field.
Beyond the Individual: Family-Level Impacts of Caregiver GLP-1 Use on Food Environments and Child Health Behaviors
Granados, Isa, Governale, Karyn M., McVay, Megan A. , Fedele, David A, McVay, Megan A , Granados, Isa , Jake‐Schoffman, Danielle E. , Fedele, David A.

Childhood Obesity | July 9, 2026 | Volume: 22 | Issue: 7 | Pages: 409-414

10.1177/21532176261467610 | PMID 42421417 Get It

Parental behaviors shape children’s obesity risk, yet little is known about family-level implications of caregiver glucagon-like peptide-1 (GLP-1) use. This cross-sectional study surveyed caregivers who started GLP-1 medication for weight management within the past 6 months and lived with at least one child aged ≤18 years ( n = 58). Guided by the Family Ecological Model, the survey assessed caregiver perceptions of family health behaviors since starting GLP-1 medication. Nearly half of caregivers reported offering healthier foods to children (46.6%) and increased focus on managing children’s nutrition and physical activity (50.0%). About one-quarter of caregivers reported healthier child eating (27.6%) and physical activity (24.1%). Most caregivers reported no change in child eating (67.2%) and physical activity (72.4%). Caregivers were more likely to report healthier foods offered following GLP-1 initiation when concern about a child’s weight had been raised by pediatrician ( p = 0.02). Caregiver GLP-1 initiation may provide an opportunity to support family-centered obesity prevention.
Global disparities in hearing care services and infrastructure: findings from a 47-country international provider survey
Zalaquett, Nader G., Frost, Robert, Stucki, Brenton R., Aggarwal, Komal, Useche, Mateo, Jaffer, Ali F. , Mokoh, Lilian Wairimu, Xu, Mary Jue , Patterson, Rolvix H., Chung, Sarah, Lageju, Nabin , Edouard, Amani , Sagun, Joyce Rodvie, Patterson, Rolvix H. , Patterson, Rolvix H , Zalaquett, Nader , Frost, Robert, Stucki, Brenton, Aggarwal, Komal , Useche, Mateo , Sagun, Joyce Rodvie, Waterworth, Christopher J.

International Journal of Audiology | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-14

10.1080/14992027.2026.2687005 | PMID 42421334 Get It

Putting CNSM Theory to the Test: Linking Interactional Sense-Making and Well-Being in the Context of Joint Family Storytelling in a Midwestern U.S. Sample
Maisano, Toni M., Kellas, Jody Koenig , Kauer, Trevor, Taladay-Carter, Cassidy, Hackenburg, Lucas , Maisano, Toni, Kauer, Trevor , Taladay-Carter, Cassidy

Journal of Family Communication | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-11

10.1080/15267431.2026.2694369 Get It

Patterns of presentation and outcomes in stage IV Hodgkin lymphoma: A report from the Children's Oncology Group ( COG ) AHOD1331
Casey, Dana L. , Renfro, Lindsay A., Wu, Yue , McCarten, Kathleen, Pei, Qinglin , Milgrom, Sarah A., Cho, Steve, Keller, Frank G., Punnett, Angela, Kelly, Kara M., Castellino, Sharon M., Hoppe, Bradford S , Casey, Dana L , McCarten, Kathleen M. , Belsky, Jennifer A. , Keller, Frank G. , Punnett, Angela , Hodgson, David , Hoppe, Bradford S. , Kelly, Kara M. , Castellino, Sharon M.

British Journal of Haematology | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/bjh.70625 | PMID 42419755 Get It

Summary Outcomes for high‐risk paediatric classic Hodgkin lymphoma (cHL) improved with the addition of brentuximab vedotin (Bv) to doxorubicin, vincristine, etoposide, prednisone and cyclophosphamide (AVEPC) chemotherapy. We evaluated the prognostic implications of distant extra‐nodal sites contributing to stage IV disease. On AHOD1331 (NCT02166463), patients aged 2–21 years with high‐risk cHL (stage IIB with bulk/IIIB/IVA/IVB) were randomized to 5 cycles of doxorubicin, bleomycin, vincristine, etoposide, prednisone and cyclophosphamide (ABVE‐PC) versus Bv‐AVEPC. Patients with stage IV disease, determined by protocol‐defined and centrally reviewed Positron Emission Tomography ‐ Computed Tomography (PET‐CT), were identified. Baseline characteristics and progression‐free survival (PFS) were compared by pattern of stage IV involvement (lung, bone, bone marrow, multiple sites and others). A total of 340 patients (median age 15 years) with stage IV disease were included. Of these patients, 173 (51%) received ABVE‐PC and 167 (49%) Bv‐AVEPC. PFS was highest with lung‐only involvement (4‐year PFS 88.6%) and lowest with bone marrow‐only involvement (4‐year PFS 71.9%). Compared to ABVE‐PC, Bv‐AVEPC improved PFS among all stage IV patients (hazard ratio [HR] 0.53, 90% confidence interval (CI) 0.33–0.85) and in the lung‐only and bone‐only subgroups. However, no PFS benefit was observed in those with bone marrow‐only involvement. Among paediatric patients with stage IV cHL, Bv‐AVEPC improved PFS across most patterns of stage IV disease, except in those with bone marrow involvement. These results will guide efforts to improve outcomes among children with stage IV cHL.
Design and validation of a stereotactic frame for independent bilateral multi-trajectory targeting
Alfonsi, Adriano , Tang-Cabrera, Jennifer , Lee, Elliott, Koller, Adam , Chen, Paul J, Scalise, Lorenzo , Hawkes, Maximiliano A, Oh, Yoonbae , Sung, Jaeyun , Shin, Hojin , Lee, Kendall H. , Koller, Adam L , Oh, Yoonbae , Sung, Jaeyun , Hawkes, Maximiliano A.

Journal of Neural Engineering | July 8, 2026 | Volume: 23 | Issue: 4 | Pages: 046031

10.1088/1741-2552/ae87cf | PMID 42419353 Get It

Abstract Objective. Modern stereotactic neurosurgery increasingly relies on bilateral and multi-trajectory workflows (e.g. deep brain stimulation (DBS), stereoelectroencephalography (sEEG)), which can exceed the reach and flexibility of conventional frame-based systems. Building on our skull-mounted Navinetics D1 platform, we present a stereotactic frame (Navinetics E1) intended to expand the reachable work envelope, enable independent bilateral targeting, and preserve mechanical accuracy and patient comfort. Approach. We designed the Navinetics E1 stereotactic frame using a center-of-arc architecture with five degrees of freedom per hemisphere ( X, Y, Z , Arc, Collar) and two operating modes: Double Arm (independent left/right arms for simultaneous bilateral targeting) and Single Arm (mechanically coupled arms). The system was designed in CAD and fabricated via carbon fiber-reinforced polylactic acid (PLA-CF) additive manufacturing. Collision-aware MATLAB simulations quantified work volume and admissible approach directions. Mechanical targeting accuracy was evaluated on a ground truth fixture (GTF) platform, with mixed-effects modeling to assess target- and trajectory-dependent effects. Operative feasibility was assessed through an intraoperative entry-point replication test relative to the D1 system. Main results. Compared to the D1, the E1 frame significantly expanded key geometric ranges, including, most notably, 0°–360° Collar rotation and posterior Y -axis reach, thereby increasing the work volume and trajectory range by factors of 3.39 and 8.42, respectively. Mean GTF targeting deviation was 0.78 ± 0.38 mm in Single Arm mode and 1.23 ± 0.36 mm (right) and 1.65 ± 0.47 mm (left) in Double Arm mode. Entry-point replication across 17 clinical cases achieved 76.5% success in overlapping the reference points, providing preliminary evidence of feasibility under real operative conditions. Significance. The E1 frame extends a compact skull-mounted platform to support broader stereotactic reach and trajectory while enabling independent bilateral workflows. These features may reduce intraoperative reconfiguration for complex DBS and sEEG cases. Future work will focus on increasing structural stiffness, improving angular readout/setting, and developing MRI-compatible implementations.
Subclinical Venous Injury in Transvenous Lead Extraction: Histological Correlation With Clinical Risk Factors
Lateef, Azalfa , Vardar, Ufuk , Hochwald, Alex, Nassar, Aziza , Ladas, Thomas, Chiriac, Anca, Niekerk, Christoffel J. van , Kusumoto, Fred , Kella, Danesh , Lateef, Azalfa U , Van Niekerk, Christoff , Kella, Danesh K , Nassar, Aziza , Kusumoto, Fred M , Hochwald, Alexander , Ladas, Thomas P. , Chiriac, Anca

Journal of Cardiovascular Electrophysiology | July 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/jce.70402 | PMID 42418820 Get It

ABSTRACT Background Transvenous lead extraction (TLE) is a commonly performed and generally safe procedure, though procedural complexity and risk can vary based on clinical and procedural factors. Objective This study aims to identify clinical and procedural factors associated with histologic evidence of subclinical vascular injury, defined by elastin positivity on extracted leads and its clinical significance. Methods Patients undergoing TLE with a lead dwell time of ≥ 1 year were included. Extracted leads with tissue were analyzed histologically using Verhoeff–Van Gieson staining to assess the presence of elastin. Demographic data, procedural and lead characteristics, and indication for extraction were obtained. Established extraction risk scores were calculated to determine efficacy in predicting subclinical vascular injury. Results The cohort included 49 patients with 92 leads extracted. A total of 25 patients (51%) had elastin‐positive leads. Complete procedural success occurred in 95.9% of cases. The multivariate regression model did not identify any independent predictors of elastin presence, including age (OR = 1.00; 95% CI 0.95–1.05; p = 0.89), female gender (OR = 3.04; 95% CI 0.67–13.65; p = 0.14), lead dwell time (OR = 1.13; 95% CI 0.98–1.29; p = 0.07). Additionally, no scoring system, such as the CCF, EROS, MB, SAFeTY, and LECOM, predicted the presence of elastin. Conclusion Subclinical venous injury was common following TLE, yet did not predict adverse clinical outcomes, reinforcing that TLE performed in experienced centers carries a favorable safety profile. Future studies in larger cohorts are needed to further characterize the clinical utility of subclinical vascular injury.
An Unexpected Encounter: When a Novel Device Algorithm Meets a Novel Ablation System
Makkar, Nayani , Mulpuru, Siva K., DeSimone, Christopher V. , Hayes, David L. , Tan, Nicholas Y. , Ezzeddine, Fatima , DeSimone, Christopher V , Tan, Nicholas , Mulpuru, Siva K. , Ezzeddine, Fatima M.

Journal of Cardiovascular Electrophysiology | July 8, 2026 | Volume: 37 | Issue: 8 | Pages: 1883-1885

10.1111/jce.70449 | PMID 42418732 Get It